Dr. Ferguson is an Assistant Professor and the student admission officer for the Division of Epidemiology at Saint Louis University School of Public Health. Dr. Ferguson research interests include cardiovascular disease, diabetes, and adverse effects of HIV/AIDS Anti-Retroviral Drug Therapies. She has experience in coordinating and data management of longitudinal epidemiologic studies in cardiovascular disease and clinical trials involving stroke and rheumatoid arthritis. Dr. Ferguson is a Certified Health Educator Specialist (CHES), and she is a member of the American Public Health Association and the Society of Public Health Educators.

Education
PhD – University of Alabama at Birmingham
MSPH - University of Alabama at Birmingham
MPH – Tulane University

Courses
EPI – 512: Chronic Disease Epidemiology

Publications
Yan LL, Liu K, Matthews KA, Daviglus ML, Ferguson TF, Kiefe CI. Psychosocial Factors and Risk of Hypertension: The CARDIA Study. JAMA, 2003; 290:2138-2148.

Ferguson TF, Stewart K, Funkhouser E, Tolson J, Pham S, Westfall AO, Saag MS. Patient Perceived Barriers to Antiretroviral Adherence: Associations with Race and Gender. AIDS Care, 2002; 14: 607 - 617.

Freeman T. Racial and Gender Differences in the Adherence to Highly Active Anti-Retroviral Therapy (HAART). Congressional Black Caucus Foundation Annual Fellows Report, 1999; 2: 11 - 21.

Greenberg SS, Lancaster JR, Xie J, Sarphie TG, Zhao X, Hua L, Freeman T, Kapusta DR, Giles TD, Powers DR. Effects of NO synthase inhibitors, arginine deficient diet, and amiloride in pregnant rats. American Journal of Physiology, 1997; 273(3 pt 2): R1031-R1045.